Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553109802844160 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Discover Oncology |
| description | |
| discipline_display | Endocrinology |
| discipline_facet | Endocrinology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:73682 |
| institution | FRELIP |
| journal_source_facet | Discover Oncology |
| last_indexed | 2026-06-20T21:31:00.656Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma Endocrinology General Endocrinology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Endocrinology General Endocrinology |
| subject_facet | Endocrinology General Endocrinology |
| title | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_alt | La regulación positiva de GFPT2 predice mal pronóstico y se asocia con la activación de TGF-β/Smad en adenocarcinoma de pulmón La surexpression de GFPT2 prédit un mauvais pronostic et est associée à l'activation de TGF-β/Smad dans l'adénocarcinome pulmonaire A regulação positiva do GFPT2 prediz mau prognóstico e está associada à ativação de TGF-β/Smad no adenocarcinoma de pulmão |
| title_auth | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_es_txt | La regulación positiva de GFPT2 predice mal pronóstico y se asocia con la activación de TGF-β/Smad en adenocarcinoma de pulmón |
| title_fr_txt | La surexpression de GFPT2 prédit un mauvais pronostic et est associée à l'activation de TGF-β/Smad dans l'adénocarcinome pulmonaire |
| title_full | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_fullStr | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_full_unstemmed | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_pt_txt | A regulação positiva do GFPT2 prediz mau prognóstico e está associada à ativação de TGF-β/Smad no adenocarcinoma de pulmão |
| title_short | GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma |
| title_sort | gfpt2 upregulation predicts poor prognosis and is associated with tgf-β/smad activation in lung adenocarcinoma |
| topic | Endocrinology General Endocrinology |
| url | https://link.springer.com/article/10.1007/s12672-026-05342-0 |